CRISPR-Cas9 gene editing of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma

被引：0

作者：

Sanber, Khaled ^{[1
]}

Nawas, Zeid ^{[1
]}

Salsman, Vita ^{[1
]}

Gad, Ahmed ^{[1
]}

Matthew, Pretty Rose ^{[1
]}

Landi, Daniel ^{[1
]}

Lee, Ciaran ^{[2
]}

Sengal, Amel ^{[1
]}

Chakraborty, Rikhia ^{[1
]}

Joseph, Sujith ^{[1
]}

Nabil, Ahmed ^{[1
]}

Hegde, Meenakshi ^{[1
]}

机构：

[1] Baylor Coll Med, Houston, TX 77030 USA

[2] Rice Univ, Houston, TX USA

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-2173

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2173

引用

页数：2

共 50 条

[1] Modulation of inhibitory receptor signaling pathways improves CAR T cell activity against glioblastoma
Sanber, K.
Nawas, Z.
Salsman, V.
Gad, A.
Mathew, P.
Landi, D.
Lee, C.
Sengal, A.
Chakraborty, R.
Joseph, S.
Ahmed, N.
Hegde, M.
CYTOTHERAPY, 2020, 22 (05) : S19 - S19
[2] Controlling CRISPR-Cas9 Gene Editing
Dowdy, Steven F.
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (03): : 289 - 290
[3] Introduction to CRISPR-Cas9 Gene Editing
Mason, J. M.
BIRTH DEFECTS RESEARCH, 2020, 112 (11): : 809 - 809
[4] Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Alexander Dimitri
Friederike Herbst
Joseph A. Fraietta
Molecular Cancer, 21
[5] Engineering the next-generation of CAR T-cells with CRISPR-Cas9 gene editing
Dimitri, Alexander
Herbst, Friederike
Fraietta, Joseph A.
MOLECULAR CANCER, 2022, 21 (01)
[6] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Norton, Mary E.
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2021, 76 (06) : 327 - 329
[7] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Haydar Frangoul
四川生理科学杂志, 2020, 42 (04) : 506 - 506
[8] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Frangoul, H.
Altshuler, D.
Cappellini, M. D.
Chen, Y-S
Domm, J.
Eustace, B. K.
Foell, J.
de la Fuente, J.
Grupp, S.
Handgretinger, R.
Ho, T. W.
Kattamis, A.
Kernytsky, A.
Lekstrom-Himes, J.
Li, A. M.
Locatelli, F.
Mapara, M. Y.
de Montalembert, M.
Rondelli, D.
Sharma, A.
Sheth, S.
Soni, S.
Steinberg, M. H.
Wall, D.
Yen, A.
Corbacioglu, S.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (03): : 252 - 260
[9] CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
Meisel, Roland
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (23):
[10] CRISPR-Cas9 T Cell Editing for Finnish Founder Diseases
Mamia, Katariina
Li, Zhuokun
Reint, Ganna
Fatkhutdinov, Nail
Haugen, Frida
Gjerdingen, Thea
Szymanska, Monika
Labun, Kornel
Olweus, Johanna
Haapaniemi, Emma
MOLECULAR THERAPY, 2022, 30 (04) : 455 - 455

← 1 2 3 4 5 →